Healthpeak Properties' (NYSE:DOC) stock performance has been varied. On the downside, its price target was lowered to $23 from $26 by Jefferies and to $22 from $23 by Wells Fargo. The stock also underperformed occasionally compared to competitors despite daily gains. However, positives include the stock's outperformance compared to competitors despite the apparent losses and its strong portfolio performance, leading to raised 2024 guidance. Multiple investments have been made in DOC, including new investments by M&T Bank Corp, Franklin Resources Inc., State Street Corp and Barclays Plc. Additionally, the company's Investor Presentation has been published, and their $3 Billion Revolving Credit Facility has been extended. A merger with Physicians Realty Trust has been completed, evidenced by the closing of the merger and their combined action to amend Physicians Realty L.P. Indentures. Deutsche Bank upgraded the company's stock to buy and cut the Price Target (PT) to $135. Finally, Healthpeak's revenue surged by 25.9% in Q3, and the company beat Q3 FFO and revenue estimates.
Healthpeak Properties DOC News Analytics from Fri, 14 Jul 2023 07:00:00 GMT to Fri, 03 Jan 2025 22:20:00 GMT -
Rating 5
- Innovation 4
- Information 6
- Rumor 1
